Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Thyroid Res. 2011;2011:361304. doi: 10.4061/2011/361304. Epub 2011 Jun 8.

Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis.

Author information

  • 1Department of Microbiology, University of California-Davis, Davis, CA 95616, USA.

Abstract

Thyroid hormone, operating through its receptors, plays crucial roles in the control of normal human physiology and development; deviations from the norm can give rise to disease. Clinical endocrinologists often must confront and correct the consequences of inappropriately high or low thyroid hormone synthesis. Although more rare, disruptions in thyroid hormone endocrinology due to aberrations in the receptor also have severe medical consequences. This review will focus on the afflictions that are caused by, or are closely associated with, mutated thyroid hormone receptors. These include Resistance to Thyroid Hormone Syndrome, erythroleukemia, hepatocellular carcinoma, renal clear cell carcinoma, and thyroid cancer. We will describe current views on the molecular bases of these diseases, and what distinguishes the neoplastic from the non-neoplastic. We will also touch on studies that implicate alterations in receptor expression, and thyroid hormone levels, in certain oncogenic processes.

PMID:
21760978
[PubMed]
PMCID:
PMC3134260
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Write to the Help Desk